A carregar...
PRE-TRANSPLANT HEMOGLOBIN AND CREATININE CLEARANCE CORRELATE WITH TREATMENT FREE SURVIVAL AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA
Melphalan is given at a dose of 200mg/m(2) (Mel200) prior to ASCT for multiple myeloma (MM). Pharmacokinetic (PK) studies show a high degree of interpatient variability. We aimed to test the impact of clinical factors previously shown to affect melphalan PK such as hemoglobin (Hgb), fat free mass (F...
Na minha lista:
| Publicado no: | Bone Marrow Transplant |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7741423/ https://ncbi.nlm.nih.gov/pubmed/31388085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-019-0628-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|